BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32434987)

  • 1. Genetic and environmental factors underlying keratinocyte carcinoma risk.
    Choquet H; Ashrafzadeh S; Kim Y; Asgari MM; Jorgenson E
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32434987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of keratinocyte cancers identifies novel genome-wide loci.
    Liyanage UE; Law MH; Han X; An J; Ong JS; Gharahkhani P; Gordon S; Neale RE; Olsen CM; ; MacGregor S; Whiteman DC
    Hum Mol Genet; 2019 Sep; 28(18):3148-3160. PubMed ID: 31174203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
    Liu-Smith F; Jia J; Zheng Y
    Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FABP5 in keratinocyte carcinomas: expression, secretion, and its impact on tumor aggressiveness.
    Matas-Nadal C; Gatius S; Ribes-Santolaria M; Guasch-Vallés M; Gomez Arbones X; Casanova JM; Aguayo-Ortiz RS; Garí E
    Arch Dermatol Res; 2024 Jun; 316(7):342. PubMed ID: 38847933
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes.
    Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A
    Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
    Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
    JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid receptor isoform mRNA expression differs between BCC and SCC of the skin.
    Hartmann F; Kosmidis M; Mühleisen B; French LE; Hofbauer GF
    Arch Dermatol; 2010 Jun; 146(6):675-6. PubMed ID: 20566936
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
    Helander SD; Peters MS; Pittelkow MR
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with basal cell carcinoma, squamous cell carcinoma, and squamous cell carcinoma in situ: A whole population study.
    Sharp K; Olafsdottir EJ; Sahni DR; Madsen S; Grant-Kels JM; Kristjansson A; Hoyt DW; Ungar JP; Frigerio A; Jonasson JG; Adalsteinsson JA
    J Am Acad Dermatol; 2024 Jan; 90(1):91-97. PubMed ID: 37758026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
    Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
    Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
    Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
    JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.
    Tang H; Fu S; Zhai S; Song Y; Asgari MM; Han J
    Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):279-288. PubMed ID: 29318704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAV3 copy number changes and target genes in basal and squamous cell cancers.
    Maliniemi P; Carlsson E; Kaukola A; Ovaska K; Niiranen K; Saksela O; Jeskanen L; Hautaniemi S; Ranki A
    Exp Dermatol; 2011 Nov; 20(11):926-31. PubMed ID: 21995814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
    Thompson BS; Olsen CM; Subramaniam P; Neale RE; Whiteman DC
    Aust N Z J Public Health; 2016 Apr; 40(2):154-8. PubMed ID: 26558736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
    Reichrath J; Rass K
    Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.
    Keim U; van der Pols JC; Williams GM; Green AC
    J Invest Dermatol; 2015 Mar; 135(3):728-733. PubMed ID: 25233075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High numbers of human skin cancers express MMP2 and several integrin genes.
    Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
    J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
    Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.